Cigna Group annual stock-based compensation
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cigna Group Stock-Based Compensation Growth & History (CI)
Cigna Group's stock-based compensation was $291.0M for fiscal 2025.
View full Cigna Group company overviewCigna Group annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $291.0M | −$17.0M | −5.52% |
| 2024 | 2024-12-31 | $308.0M | $22.0M | +7.69% |
| 2023 | 2023-12-31 | $286.0M | $22.0M | +8.33% |
| 2022 | 2022-12-31 | $264.0M | −$4.0M | −1.49% |
| 2021 | 2021-12-31 | $268.0M | −$21.0M | −7.27% |
| 2020 | 2020-12-31 | $289.0M | −$10.0M | −3.34% |
| 2019 | 2019-12-31 | $299.0M | $119.0M | +66.11% |
| 2018 | 2018-12-31 | $180.0M | $2.0M | +1.12% |
| 2017 | 2017-12-31 | $178.0M | $50.0M | +39.06% |
| 2016 | 2016-12-31 | $128.0M | — | — |
Cigna Group stock-based compensation trends
Over the last five fiscal years, Cigna Group's stock-based compensation increased from $289.0M to $291.0M, a change of $2.0M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cigna Group source filings ↗